EPCAM and cancer: A drawback of using CTCs as diagnostic biomarkers is their apparent lack of specificity, as its detection relies on the use of pan-cancer markers such as epithelial cell adhesion molecule (EpCAM) and creatine kinase (CK), among others [57].